Historical Commentary | Published:

Lymphocytes, Jim Gowans and in vivo veritas

Nature Immunology volume 11, pages 10731075 (2010) | Download Citation

Jim Gowans opened a new era of immunology by combining physiological in vivo studies with prospective enrichment of small lymphocytes, validating the clonal selection theory, discovering lymphocyte homing and recirculation, and training others to follow.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Immunol. Rev. 185, 159–174 (2002).

  2. 2.

    The Clonal Selection Theory of Acquired Immunology (Cambridge University Press, London, 1959).

  3. 3.

    & J. Exp. Med. 102, 179 (1955).

  4. 4.

    Folia Haematol. (Leipzig) 8, 125–141 (1909).

  5. 5.

    Ann. NY Acad. Sci. 99, 432–455 (1962).

  6. 6.

    J. Physiol. (Lond.) 146, 54–69 (1959).

  7. 7.

    , , & Nature 196, 651–655 (1962).

  8. 8.

    & J. Exp. Med. 117, 303–320 (1963).

  9. 9.

    & Proc. R. Soc. Lond. B 159, 257–282 (1964).

  10. 10.

    & Proc. R. Soc. Lond. B 159, 283–290 (1964).

  11. 11.

    & Proc. R. Soc. Lond. B 168, 244–262 (1967).

  12. 12.

    , & Proc. R. Soc. Lond. B 168, 229–243 (1967).

  13. 13.

    & J. Exp. Med. 124, 1017–1030 (1966).

  14. 14.

    , , , & J. Exp. Med. 136, 499–513 (1972).

  15. 15.

    & Proc. R. Soc. Lond. B 183, 125–139 (1973).

  16. 16.

    & J. Exp. Med. 126, 443–454 (1967).

  17. 17.

    , , & Nat. New Biol. 233, 225–229 (1971).

  18. 18.

    & Eur. J. Immunol. 2, 523–535 (1972).

  19. 19.

    J. Exp. Med. 126, 291–304 (1967).

  20. 20.

    J. Exp. Med. 137, 504–510 (1973).

  21. 21.

    , & Eur. J. Immunol. 10, 556–561 (1980).

  22. 22.

    , & Nature 304, 30–34 (1983).

  23. 23.

    et al. Cell 44, 673–680 (1986).

  24. 24.

    , & Science 243, 1165–1172 (1989).

  25. 25.

    , & Cell 56, 37–46 (1989).

  26. 26.

    , & J. Exp. Med. 123, 191–204 (1966).

  27. 27.

    & Immunology 23, 465–479 (1972).

  28. 28.

    , , , & Hum. Pathol. 9, 25–45 (1978).

  29. 29.

    , & Cell 44, 653–662 (1986).

  30. 30.

    , & Science 241, 58–62 (1988).

  31. 31.

    , , , & Proc. Natl. Acad. Sci. USA 89, 2804–2808 (1992).

  32. 32.

    et al. Proc. Natl. Acad. Sci. USA 97, 14720–14725 (2000).

  33. 33.

    et al. Cell 119, 543–554 (2004).

  34. 34.

    et al. Nature 457, 490–494 (2009).

  35. 35.

    , & Proc. Natl. Acad. Sci. USA 97, 7521–7526 (2000).

  36. 36.

    et al. N. Engl. J. Med. 351, 657–667 (2004).

  37. 37.

    , & Cell 119, 431–443 (2004).

  38. 38.

    et al. Proc. Natl. Acad. Sci. USA 103, 6224–6229 (2006).

  39. 39.

    et al. Proc. Natl. Acad. Sci. USA 104, 973–978 (2007).

  40. 40.

    et al. Proc. Natl. Acad. Sci. USA 106, 3396–3401 (2009).

  41. 41.

    et al. Proc. Natl. Acad. Sci. USA 106, 3925–3929 (2009).

  42. 42.

    et al. Proc. Natl. Acad. Sci. USA 106, 14016–14021 (2009).

  43. 43.

    Nat. Immunol. 2, 569–571 (2001).

  44. 44.

    Nat. Immunol. 2, 981–982 (2001).

Download references

Author information

Affiliations

  1. Irving Weissman is at Stanford University, Palo Alto, California, USA.

    • Irving Weissman

Authors

  1. Search for Irving Weissman in:

Competing interests

I.W. owns Amgen stock and is a director and consultant for Stem Cells.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni1210-1073

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing